Tomoxetina [Spanish]
Tomoxetina [Spanish] Brand names, Tomoxetina [Spanish] Analogs
Tomoxetina [Spanish] Brand Names Mixture
- No information avaliable
Tomoxetina [Spanish] Chemical_Formula
C17H21NO
Tomoxetina [Spanish] RX_link
http://www.rxlist.com/cgi/generic3/strattera.htm
Tomoxetina [Spanish] fda sheet
Tomoxetina [Spanish] msds (material safety sheet)
Tomoxetina [Spanish] Synthesis Reference
No information avaliable
Tomoxetina [Spanish] Molecular Weight
255.355 g/mol
Tomoxetina [Spanish] Melting Point
No information avaliable
Tomoxetina [Spanish] H2O Solubility
No information avaliable
Tomoxetina [Spanish] State
Solid
Tomoxetina [Spanish] LogP
4.656
Tomoxetina [Spanish] Dosage Forms
Capsule
Tomoxetina [Spanish] Indication
For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
Tomoxetina [Spanish] Pharmacology
Atomoxetine is an amphetamine used to treat ADD/ADHD in children and adults. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. It increases motor activity and mental alertness, and reduces drowsiness and a sense of fatigue, decreasing motor restlessness and improves one's ability to focus. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence which clearly establishes the mechanism whereby amphetamine produces mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system. Atomoxetine activates the brain stem arousal system and cortex to produce its stimulant effect.
Tomoxetina [Spanish] Absorption
No information avaliable
Tomoxetina [Spanish] side effects and Toxicity
No information avaliable
Tomoxetina [Spanish] Patient Information
Tomoxetina [Spanish] Organisms Affected
Humans and other mammals
![Tomoxetina_[Spanish]](/images/rx/APRD00614.gif)
